The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection.

/in /by

Koh AY.  The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection. PLoS Pathogens 2017 Jun 29; 13(6):e1006342. PMID: 28662165.   There is no Abstract link.  Full Text

You might also like
The complexities of bacterial-fungal interactions in the mammalian gastrointestinal tract.
Functional Mapping and Analysis Pipeline for metagenomics and metatranscriptomics studies.
Candida albicans inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis.
Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization.
RNA Isolation of Pseudomonas aeruinosa Colonizing the Murine Gastrointestinal Tract.
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients.
Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients.
Collaboration between macrophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia.